[1]刘 美.孟鲁司特钠联合复方甲氧那明治疗慢性支气管炎的临床疗效及对肺功能的影响[J].医学信息,2022,35(22):83-85.[doi:10.3969/j.issn.1006-1959.2022.22.015]
　LIU Mei.Clinical Effect of Montelukast Sodium Combined with Compound Methoxyphenamine in the Treatment of Chronic Bronchitis and its Influence on Pulmonary Function[J].Journal of Medical Information,2022,35(22):83-85.[doi:10.3969/j.issn.1006-1959.2022.22.015]
点击复制

孟鲁司特钠联合复方甲氧那明治疗慢性支气管炎的临床疗效及对肺功能的影响()
分享到：

医学信息[ISSN:1006-1959/CN:61-1278/R]

卷:
35卷
期数:
2022年22期
页码:
83-85
栏目:
论著
出版日期:
2022-11-15

文章信息/Info

Title:
Clinical Effect of Montelukast Sodium Combined with Compound Methoxyphenamine in the Treatment of Chronic Bronchitis and its Influence on Pulmonary Function
文章编号:
1006-1959（2022）22-0083-03
作者:
刘 美
（天津市宁河区医院呼吸与危重症医学科，天津 301500）
Author(s):
LIU Mei
(Department of Respiratory and Critical Care Medicine,Tianjin Ninghe District Hospital,Tianjin 301500,China)
关键词:
孟鲁司特钠; 复方甲氧那明; 慢性支气管炎; 肺功能
Keywords:
Montelukast sodium; Compound methoxyphenamine; Bronchitis; Lung function
分类号:
R562.2+1
DOI:
10.3969/j.issn.1006-1959.2022.22.015
文献标志码:
A
摘要:
目的 研究孟鲁司特钠联合复方甲氧那明治疗慢性支气管炎的临床疗效及对肺功能的影响。方法 选取2020年4月-2021年4月于我院诊治的72例慢性支气管炎患者为研究对象，采用随机数字表法分为对照组和观察组，各36例。对照组采用孟鲁司特钠治疗，观察组在对照组基础上联合复方甲氧那明治疗，比较两组临床疗效、肺功能指标、炎症因子指标、临床症状缓解时间、不良反应发生率。结果 观察组治疗总有效率为94.44%，高于对照组的80.56%（P＜0.05）；两组治疗后呼气峰流速（PEF）、肺活量（FVC）、第1秒用力呼气量（FEV1）均高于治疗前，且观察组高于对照组（P＜0.05）；两组治疗后C反应蛋白（CRP）、白细胞（WBC）水平均低于治疗前，且观察组低于对照组（P＜0.05）；观察组咳嗽、喘息、咳痰各症状缓解时间均短于对照组（P＜0.05）；观察组不良反应发生率为5.56%，低于对照组的8.33%，但差异无统计学意义（P＞0.05）。结论 孟鲁司特钠联合复方甲氧那明治疗慢性支气管炎疗效确切，可提高总有效率，改善肺功能指标，促进炎症因子吸收，快速缓解临床症状，且不会增加不良反应。
Abstract:
Objective To study the clinical efficacy of montelukast sodium combined with compound methoxyphenamine in the treatment of chronic bronchitis and its effect on pulmonary function.Methods A total of 72 patients with chronic bronchitis diagnosed and treated in our hospital from April 2020 to April 2021 were selected as the research objects. They were divided into control group and observation group by random number table method, with 36 cases in each group. The control group was treated with montelukast sodium, and the observation group was treated with compound methoxyphenamine on the basis of the control group. The clinical efficacy, pulmonary function index, inflammatory factor index, clinical symptom relief time and incidence of adverse reactions were compared between the two groups.Results The total effective rate of the observation group was 94.44%, which was higher than 80.56% of the control group (P<0.05). The peak expiratory flow (PEF), forced vital capacity (FVC) and the forced expiratory volume in one second (FEV1) of the two groups after treatment were higher than those before treatment, and those in the observation group wwere higher than those in the control group (P<0.05). After treatment, the levels of C-reactive protein (CRP) and white blood cell (WBC) in the two groups were lower than those before treatment, and those in the observation group were lower than those in the control group (P<0.05). The remission time of cough, wheezing and expectoration in the observation group was shorter than that in the control group (P<0.05). The incidence of adverse reactions in the observation group was 5.56%, which was lower than 8.33% in the control group, but there is no significant difference(P>0.05).Conclusion Montelukast sodium combined with compound methoxyphenamine is effective in the treatment of chronic bronchitis, which can improve the total effective rate, improve lung function index, promote the absorption of inflammatory factors, quickly relieve clinical symptoms, and will not increase adverse reactions.

参考文献/References:

[1]魏兵,畅怡,赵松林,等.208例慢性咳嗽患者的临床病例分析[J].临床肺科杂志,2017,22(8):1418-1421.[2]郑建珅.金振口服液联合孟鲁司特钠治疗小儿支气管炎的临床研究[J].现代药物与临床,2018,33(3):537-540.[3]王少燕.肺力咳合剂联合孟鲁司特治疗小儿急性支气管炎49例临床研究[J].中国药物与临床,2019,19(12):2060-2062.[4]中华医学会呼吸病学分会哮喘学组.咳嗽的诊断与治疗指南（2021）[J].中华结核和呼吸杂志,2022,45(1):13-46.[5]张佑,吴双.孟鲁司特钠联合苏黄止咳胶囊治疗咳嗽变异性哮喘的临床疗效及安全性研究[J].山西医药杂志,2017,46(16):1990-1992.[6]吴国清.止咳化痰方治疗慢性支气管炎急性发作的临床观察[J].中国中医药科技,2019,26(3):440-441.[7]谢华,刘美岑,宋迪,等.住院慢性支气管炎患者合并支气管扩张调查分析[J].临床军医杂志,2017,45(8):790-792,795.[8]段礼雪,陈建堂.盐酸氨溴索辅助治疗慢性支气管炎急性发作的效果评价[J].中国基层医药,2018,25(16):2053-2056.[9]徐琳琳,周瑞清,郑法德,等.糖皮质激素联合特布他林雾化吸入治疗慢性阻塞性肺疾病急性加重患者的临床疗效及其对肺功能的影响[J].实用心脑肺血管病杂志,2021,29(7):18-23.[10]刘琴,钱静燕,冯绍中.佳贝咳喘宁2号治疗慢性喘息性支气管炎急性发作期临床观察[J].中国中医急症,2017,26(7):1247-1249.[11]姚改宪,邓静修,王道豹.阿奇霉素与左氧氟沙星门诊治疗慢性支气管炎急性发作的对照研究[J].中西医结合心血管病电子杂志,2017,5(25):133,136.[12]张金波,王新陆,孙丽,等.清肺化浊行血宽中方对PM2.5引起慢性支气管炎大鼠肺组织病理学及血清IL-8、TNF-α的影响[J].中华全科医学,2017,15(12):2028-2031.[13]朱念,金文静,王志华.孟鲁司特钠辅助治疗哮喘-慢性阻塞性肺疾病重叠患者的临床疗效[J].实用心脑肺血管病杂志,2019,27(4):95-98.[14]王刚.噻托溴铵联合沙美特罗替卡松吸入治疗慢性喘息性支气管炎的效果分析[J].临床与病理杂志,2019,39(5):1029-1033.[15]金瑄,王丽.干扰素α_1b联合孟鲁司特钠治疗小儿喘息性支气管炎疗效观察[J].海南医学,2017,28(4):654-655.[16]于海梅,高捷,钟晓,等.口服孟鲁司特钠联合布地奈德及复方异丙托溴氨雾化治疗儿童支气管哮喘前后单核细胞趋化蛋白-4的变化情况[J].中国药物与临床,2017,17(4):553-556.[17]王斌,吴静华,李永权.孟鲁司特钠治疗小儿喘息性支气管炎的疗效及对气道高反应性的预防效果分析[J].医学综述,2016,22(8):1600-1602.[18]谢建明.复方甲氧那明治疗上呼吸道感染后咳嗽的疗效分析[J].山西医药杂志,2019,48(1):66-68.[19]王新军.孟鲁司特钠联合复方甲氧那明对慢性支气管炎患者症状改善及不良反应发生率的影响[J].黑龙江医药科学,2018,41(4):72-73.[20]周文波．特布他林联合复方甲氧那明胶囊治疗咳嗽变异性哮喘的临床研究[J]．现代药物与临床,2017,32(10):1881-1884．

相似文献/References:

[1]李波.孟鲁司特钠联合酮替芬治疗小儿支气管炎的临床效果分析[J].医学信息,2018,31(02):130.[doi:10.3969/j.issn.1006-1959.2018.02.048]
　LI Bo.Clinical Analysis of Montelukast Sodium Combined With Ketotifen in the Treatment of Bronchitis in Children[J].Journal of Medical Information,2018,31(22):130.[doi:10.3969/j.issn.1006-1959.2018.02.048]
[2]尹静华.孟鲁司特钠治疗小儿哮喘的临床有效性分析[J].医学信息,2018,31(09):138.[doi:10.3969/j.issn.1006-1959.2018.09.043]
　YIN Jing-hua.Clinical Efficacy of Montelukast Sodium in Children with Asthma[J].Journal of Medical Information,2018,31(22):138.[doi:10.3969/j.issn.1006-1959.2018.09.043]
[3]张明荣.孟鲁司特钠联合布地奈德治疗小儿哮喘的临床疗效分析[J].医学信息,2018,31(13):131.[doi:10.3969/j.issn.1006-1959.2018.13.038]
　ZHANG Ming-rong.Clinical Analysis of Montelukast Sodium Combined with Budesonide in the Treatment of Childhood Asthma[J].Journal of Medical Information,2018,31(22):131.[doi:10.3969/j.issn.1006-1959.2018.13.038]
[4]韦春峥,莫 彬,莫善圆,等.孟鲁司特钠联合布地奈德治疗儿童支气管哮喘合并变应性鼻炎的临床效果[J].医学信息,2019,32(20):142.[doi:10.3969/j.issn.1006-1959.2019.20.044]
　WEI Chun-zheng,MO Bin,MO Shan-yuan,et al.Clinical Effect of Montelukast Sodium Combined with Budesonide in the Treatment of Children with Bronchial Asthma Complicated with Allergic Rhinitis[J].Journal of Medical Information,2019,32(22):142.[doi:10.3969/j.issn.1006-1959.2019.20.044]
[5]甘 瀛.孟鲁司特钠联合布地奈德治疗小儿咳嗽变异性哮喘的疗效[J].医学信息,2019,32(12):150.[doi:10.3969/j.issn.1006-1959.2019.12.049]
　GAN Ying.Efficacy of Montelukast Sodium Combined with Budesonide in the Treatment of Cough Variant Asthma in Children[J].Journal of Medical Information,2019,32(22):150.[doi:10.3969/j.issn.1006-1959.2019.12.049]
[6]凌春艳.布地奈德气雾剂联合孟鲁司特钠治疗老年咳嗽变异性哮喘的疗效[J].医学信息,2020,33(07):144.[doi:10.3969/j.issn.1006-1959.2020.07.046]
　LING Chun-yan.Efficacy of Budesonide Aerosol Combined with Montelukast Sodium in the Treatment of Elderly Cough Variant Asthma[J].Journal of Medical Information,2020,33(22):144.[doi:10.3969/j.issn.1006-1959.2020.07.046]
[7]牛春生.孟鲁司特钠联合糠酸莫米松治疗过敏性鼻炎致轻中度腺样体肥大的效果[J].医学信息,2020,33(22):153.[doi:10.3969/j.issn.1006-1959.2020.22.044]
　NIU Chun-sheng.The Effect of Montelukast Sodium Combined with Mometasone Furoate in the Treatment of Mild to Moderate Adenoid Hypertrophy Caused by Allergic Rhinitis[J].Journal of Medical Information,2020,33(22):153.[doi:10.3969/j.issn.1006-1959.2020.22.044]
[8]张广平.孟鲁司特钠治疗病毒性小儿哮喘的临床疗效及安全性[J].医学信息,2021,34(23):105.[doi:10.3969/j.issn.1006-1959.2021.23.030]
　ZHANG Guang-ping.Clinical Efficacy and Safety of Montelukast Sodium in the Treatment of Viral Asthma in Children[J].Journal of Medical Information,2021,34(22):105.[doi:10.3969/j.issn.1006-1959.2021.23.030]
[9]金彩英.孟鲁司特钠治疗儿童呼吸道合胞病毒感染毛细支气管炎的效果及其对炎症因子的影响[J].医学信息,2022,35(01):162.[doi:10.3969/j.issn.1006-1959.2022.01.040]
　JIN Cai-ying.Effect of Montelukast Sodium on Bronchiolitis Caused by Respiratory Syncytial Virus Infection in Children and its Effect on Inflammatory Factors[J].Journal of Medical Information,2022,35(22):162.[doi:10.3969/j.issn.1006-1959.2022.01.040]
[10]张 健.孟鲁司特钠联合氯雷他定治疗小儿过敏性紫癜的疗效及对炎性因子、免疫球蛋白水平的影响[J].医学信息,2022,35(15):107.[doi:10.3969/j.issn.1006-1959.2022.15.024]
　ZHANG Jian.Effect of Montelukast Sodium Combined with Loratadine in the Treatment of Anaphylactoid Purpura in Children and its Effect on Inflammatory Factors and Immunoglobulin Levels[J].Journal of Medical Information,2022,35(22):107.[doi:10.3969/j.issn.1006-1959.2022.15.024]

更新日期/Last Update: 1900-01-01